PP 3

EGFR-kinase inhibitor. Also Src kinase negative control CAS# 5334-30-5

PP 3

Catalog No. BCC7486----Order now to get a substantial discount!

Product Name & Size Price Stock
PP 3: 5mg $115 In Stock
PP 3: 10mg Please Inquire In Stock
PP 3: 20mg Please Inquire Please Inquire
PP 3: 50mg Please Inquire Please Inquire
PP 3: 100mg Please Inquire Please Inquire
PP 3: 200mg Please Inquire Please Inquire
PP 3: 500mg Please Inquire Please Inquire
PP 3: 1000mg Please Inquire Please Inquire
Related Products
  • PP 1

    Catalog No.:BCC3630
    CAS No.:172889-26-8

Quality Control of PP 3

Number of papers citing our products

Chemical structure

PP 3

3D structure

Chemical Properties of PP 3

Cas No. 5334-30-5 SDF Download SDF
PubChem ID 4879 Appearance Powder
Formula C11H9N5 M.Wt 211.22
Type of Compound N/A Storage Desiccate at -20°C
Solubility Soluble to 100 mM in DMSO and to 25 mM in ethanol
Chemical Name 1-phenylpyrazolo[3,4-d]pyrimidin-4-amine
SMILES C1=CC=C(C=C1)N2C3=C(C=N2)C(=NC=N3)N
Standard InChIKey KKDPIZPUTYIBFX-UHFFFAOYSA-N
Standard InChI InChI=1S/C11H9N5/c12-10-9-6-15-16(11(9)14-7-13-10)8-4-2-1-3-5-8/h1-7H,(H2,12,13,14)
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of PP 3

DescriptionNegative control for the Src kinase inhibitor PP 2. Inhibits EGFR kinase (IC50 = 2.7 μM).

PP 3 Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

PP 3 Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of PP 3

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 4.7344 mL 23.672 mL 47.344 mL 94.688 mL 118.36 mL
5 mM 0.9469 mL 4.7344 mL 9.4688 mL 18.9376 mL 23.672 mL
10 mM 0.4734 mL 2.3672 mL 4.7344 mL 9.4688 mL 11.836 mL
50 mM 0.0947 mL 0.4734 mL 0.9469 mL 1.8938 mL 2.3672 mL
100 mM 0.0473 mL 0.2367 mL 0.4734 mL 0.9469 mL 1.1836 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University
Featured Products
New Products
 

References on PP 3

Use of a pharmacophore model for the design of EGF-R tyrosine kinase inhibitors: 4-(phenylamino)pyrazolo[3,4-d]pyrimidines.[Pubmed:9357527]

J Med Chem. 1997 Oct 24;40(22):3601-16.

In the course of the random screening of a pool of CIBA chemicals, the two pyrazolopyrimidines 1 and 2 have been identified as fairly potent inhibitors of the EGF-R tyrosine kinase. Using a pharmacophore model for ATP-competitive inhibitors interacting with the active site of the EGF-R protein tyrosine kinase (PTK), the class of the pyrazolo[3,4-d]pyrimidines was then optimized in an interactive process leading to a series of 4-(phenylamino)-1H-pyrazolo[3,4-d]-pyrimidines as highly potent inhibitors of the EGF-R tyrosine kinase. The most potent compounds 13, 14, 15, 17, 19, 22, 26, 28, and 30 of this series inhibited the EGF-R PTK with IC50 values below 10 nM. High selectivity toward a panel of nonreceptor tyrosine kinases (c-Src, v-Abl and serine/threonine kinases (PKC alpha, CDK1) was observed. In cells, EGF-stimulated cellular tyrosine phosphorylation was inhibited by compounds 13, 15, 19, 22, and 23 at IC50 values below 50 nM, whereas PDGF-induced tyrosine phosphorylation was not affected by concentrations up to 10 microM, thus indicating high selectivity for the inhibition of the ligand-activated EGF-R signal transduction pathway. Compounds 15 and 19 inhibited proliferation of the EGF-dependent MK cell line with IC50 values below 0.5 microM. In addition, two compounds, 9 and 11, showing satisfactory oral bioavailability in mice after oral administration, exhibited good in vivo efficacy at doses of 12.5 and 50 mg/kg in a nude mouse tumor model using xenografts of the EGF-R overexpressing A431 cell line. From SAR studies, a binding mode for 4-(phenylamino)-1H-pyrazolo[3,4-d]pyrimidines, especially for compound 15, at the ATP-binding site of the EGF-R tyrosine kinase is proposed. 4-(Phenylamino)-1H-pyrazolo[3,4-d]pyrimidines represent a new class of highly potent tyrosine kinase inhibitors which preferentially inhibit the EGF-mediated signal transduction pathway and have the potential for further evaluation as anticancer agents.

Keywords:

PP 3,5334-30-5,Natural Products,Src, buy PP 3 , PP 3 supplier , purchase PP 3 , PP 3 cost , PP 3 manufacturer , order PP 3 , high purity PP 3

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: